|
1 |
“Attack!” Cellular Therapies to Attack Pathogens and Tumors
Enthalten in Transfusion medicine and hemotherapy Bd. 52, 2025, Nr. 1: 1-4. 4 S.
|
|
|
2 |
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
Bönig, Halvard. - Freiburg : Universität, 2024
|
|
|
|
3 |
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitis
Frueh, Jochen T.. - Freiburg : Universität, 2024
|
|
|
|
4 |
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patients
Bethge, Wolfgang A.. - Würzburg : Universität Würzburg, 2024
|
|
|
|
5 |
The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells
Enthalten in European journal of immunology 26.02.2024. 13 S.
|
|
|
|
6 |
Automatic generation of alloreactivity-reduced donor lymphocytes and hematopoietic stem cells from the same mobilized apheresis product
Wiercinska, Eliza. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2023
|
|
|
|
7 |
Impact of mesenchymal stromal cell–derived vesicular cargo on B-cell acute lymphoblastic leukemia progression
Karantanou, Christina. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2023
|
|
|
|
8 |
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Bönig, Halvard. - Freiburg : Universität, 2023
|
|
|
|
9 |
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Bönig, Halvard. - Ulm : Universität Ulm, 2023
|
|
|
|
10 |
The activating receptor NKp65 is selectively expressed by human ILC3 and demarcates ILC3 from mature NK cells
Kühnel, Ines. - Frankfurt am Main : Universitätsbibliothek Johann Christian Senckenberg, 2023
|
|
Administration
